| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.3 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.3 |